rebamipide 2%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rebamipide 2%, covering 2018-12-04 to 2018-12-04. Get the full timeline:
Most recent: Clinical Trial Update: Comparison Between Rebamipide 2% Versus Autologous Serum [Phase 4]